Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.
about
Preoperative, intraoperative and postoperative risk factors for anastomotic leakage after laparoscopic low anterior resection with double stapling technique anastomosisA Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal CancerImmunological Landscape and Clinical Management of Rectal CancerNew Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal CancerNeoadjuvant Rectal (NAR) Score: a New Surrogate Endpoint in Rectal Cancer Clinical TrialsNeoadjuvant chemoradiation therapy and pathological complete response in rectal cancerCurrent treatment of rectal cancer adapted to the individual patientRisk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancersRectal cancer: An evidence-based update for primary care providersReview of systemic therapies for locally advanced and metastatic rectal cancerDissecting the molecular mechanism of ionizing radiation-induced tissue damage in the feather follicleLocally advanced rectal cancer: management challengesPharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and RadiationIntensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visitsUse of adjuvant chemotherapy in stage C (III) rectal cancer: comparison of data from matched patients in a teaching hospital's clinico-pathological database.Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study.The outcomes of therapeutic decision in lower 3rd rectal cancer patientsCD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survivalNeoadjuvant therapy before surgical treatmentNeo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience.Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.Magnetic resonance imaging for diagnosis and neoadjuvant treatment evaluation in locally advanced rectal cancer: A pictorial review.Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer.Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior?Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancerBone marrow tolerance during postoperative chemotherapy in colorectal carcinomas.The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.Evidence based radiation oncology with existing technologyLymphangiogenesis in regional lymph nodes is an independent prognostic marker in rectal cancer patients after neoadjuvant treatmentMultidisciplinary treatment of rectal cancer in 2014: where are we going?Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapyOxaliplatin-based adjuvant chemotherapy without radiotherapy can improve the survival of locally-advanced rectal cancerTherapeutic approaches in the management of locally advanced rectal cancer.Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancerRoutine preventive care and cancer surveillance in long-term survivors of colorectal cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol LTS-01Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation
P2860
Q26739044-408E56EB-D6BD-46FE-B92D-88B9249017ECQ26739607-EDF9F729-96B9-4929-923C-20B0217ECE5AQ26768531-4965E7C4-102D-483A-962D-AEAD685180F5Q26786311-B282BED4-27A8-4EF3-9C41-22CA6F1A4A91Q26796253-8266917C-F88B-419E-8ECF-5D0107A0645BQ26796352-80354929-1C83-4179-96BA-F88BD35A3DBCQ26824553-B2C1AA97-A565-4228-B647-C95863F9E762Q26853016-BD2D972B-48CC-4439-AC7A-D89000B68493Q27013068-F1A4A4AA-1940-47FC-B67A-747B2966256BQ27021105-FE674069-1EE2-4611-8C81-36BB42EC1311Q27321224-611B6D8A-CFB1-4768-A04F-0FAE8BA87EE0Q28072618-CA0577F3-AB3D-48CE-B72E-6692C86FF0ABQ30300958-5626BFE0-6AA5-4371-A6F7-E717981A92BDQ30425396-31296C83-4790-4636-B52D-C95BBDBE0F0AQ30557842-F7A1DB7A-9687-4B78-B886-440D4C6E9CB9Q31138958-42AC2BA8-CB98-491C-8A57-A2668A7605B6Q33411783-07442BC1-82AE-440A-B49D-B55219C854B6Q33416945-E86B1B88-9D35-4199-859E-073257949D5BQ33595144-3AD9E19A-37D5-40FD-92CA-CFCA95774821Q33615807-7F75FC8C-E82F-4D3D-BA4B-1468AEBA9D43Q33697924-00C65D48-5AC6-4146-B11C-81425F2056F3Q33729118-DD6EE5A6-34D4-4D4B-98D0-AD58AF78EC35Q33749847-087A3F83-9AE4-4B2B-B4C6-A98E2FFA7F94Q33776709-FF98F52B-E8D0-492B-8FE4-F6F0B536AA57Q33779869-34CE77A5-1E88-4A70-BD51-E726B17B093CQ33798353-A6FE9E4C-370F-4A37-8CB2-2DAD5400B607Q33849039-E71B3A76-CFEF-4650-901A-3356E69E9A19Q33890616-D0195D26-DF6B-4869-9D6F-CFA8D18203B7Q33895624-E2415A76-C1E4-46A9-B28E-A384F8BC7057Q33914174-A1F0AF41-FCC2-49DE-8818-C7E012534005Q33922185-9A216660-AE32-426F-B717-B0D4F3B1DF4BQ34075667-331EBEE5-A9AB-43C8-845E-837215EADA1FQ34093825-C25932D4-DA13-41E0-8CF1-E888A81BE376Q34169310-A4AED9FB-5A7C-4A00-BF70-E7B54DB19AC4Q34175876-32A34802-7B84-4F99-B0F2-F9578620E502Q34226859-28E210D9-D294-43E9-A807-B31BFF4C5824Q34234928-40211149-ADDA-4CA5-920B-EBB402F115A0Q34359506-205D8415-25DB-44A9-94BA-453FD3212A2EQ34477834-EA517063-802A-4421-9FC5-B3896416E5C7Q34499179-B6BF7AAF-2BEA-4DFD-8B9A-D3C78BF73A0D
P2860
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preoperative multimodality the ...... oma of the rectum: NSABP R-03.
@en
Preoperative multimodality the ...... oma of the rectum: NSABP R-03.
@nl
type
label
Preoperative multimodality the ...... oma of the rectum: NSABP R-03.
@en
Preoperative multimodality the ...... oma of the rectum: NSABP R-03.
@nl
prefLabel
Preoperative multimodality the ...... oma of the rectum: NSABP R-03.
@en
Preoperative multimodality the ...... oma of the rectum: NSABP R-03.
@nl
P2093
P2860
P356
P1476
Preoperative multimodality the ...... oma of the rectum: NSABP R-03.
@en
P2093
Carmen J Allegra
Carol S Ursiny
Greg Yothers
Linda H Colangelo
Luis Baez-Diaz
Mark S Roh
Melvin Deutsch
Michael J O'Connell
Morton S Kahlenberg
Nicholas J Petrelli
P2860
P304
P356
10.1200/JCO.2009.22.0467
P407
P577
2009-09-21T00:00:00Z